Memory T cell proliferative responses and IFN-γ productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease

Veterinary Research

Volumn 45, Issue 1, 2014, Pages

  Ferrari, Luca ^a   Borghetti, Paolo ^a   De Angelis, Elena ^a   Martelli, Paolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MITOGENIC AGENT; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CELLULAR IMMUNITY; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; POLYMERASE CHAIN REACTION; SWINE; SWINE DISEASE; T LYMPHOCYTE; VIROLOGY;

ANIMALS; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; ENZYME-LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MITOGENS; POLYMERASE CHAIN REACTION; SWINE; SWINE DISEASES; T-LYMPHOCYTES; VIRAL VACCINES;

EID: 84899637342     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-45-44     Document Type: Article

References (49)

1. Quantification of porcine circovirus type 2 (PCV2) DNA in serum and tonsillar, nasal, tracheo-bronchial, urinary and faecal swabs of pigs with and without postweaning multisystemic wasting syndrome (PMWS). Segalés J, Calsamiglia M, Olvera A, Sibila M, Badiella L, Domingo M, Vet Microbiol 2005 111 223 229 10.1016/j.vetmic.2005.10.008 16289542 (Pubitemid 41681687)
2. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Segalés J, Virus Res 2012 164 10 19 10.1016/j.virusres.2011.10.007 22056845
3. Characteristics of porcine circovirus-2 replication in lymphoid organs of pigs inoculated in late gestation or postnatally and possible relation to clinical and pathological outcome of infection. Sanchez RE Jr, Meerts P, Nauwynck HJ, Ellis JA, Pensaert MB, J Vet Diagn Invest 2004 16 175 185 10.1177/104063870401600301 15152830 (Pubitemid 38641747)
4. Increased porcine circovirus type 2 replication in porcine leukocytes in vitro and in vivo by concanavalin A stimulation. Lefebvre DJ, Meerts P, Costers S, Misinzo G, Barbé F, Van Reeth K, Nauwynck HJ, Vet Microbiol 2008 132 74 86 10.1016/j.vetmic.2008.05.004 18556150
5. Characterization of porcine circovirus type 2 (PCV2) infection in swine lymphocytes using mitogen-stimulated peripheral blood lymphocytes from healthy PCV2-carrier pigs. Lin CM, Jeng CR, Chang HW, Guo IC, Huang YL, Tsai YC, Chia MY, Pang VF, Vet Immunol Immunopathol 2008 124 355 366 10.1016/j.vetimm.2008.04. 019 18554727
6. Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by postweaning multisystemic wasting syndrome. Darwich L, Pié S, Rovira A, Segalés J, Domingo M, Oswald IP, Mateu E, J Gen Virol 2003 84 2117 2125 10.1099/vir.0.19124-0 12867643 (Pubitemid 36927242)
7. Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens. Darwich L, Balasch M, Plana-Durán J, Segalés J, Domingo M, Mateu E, J Gen Virol 2003 84 3453 3457 10.1099/vir.0.19364-0 14645926 (Pubitemid 37540773)
8. Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses. Kekarainen T, Montoya M, Mateu E, Segalés J, J Gen Virol 2008 89 760 765 10.1099/vir.0.83354-0 18272768
9. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses. Kekarainen T, Montoya M, Dominguez J, Mateu E, Segalés J, Vet Immunol Immunopathol 2008 124 41 49 10.1016/j.vetimm.2008.01.031 18304652
10. Innate pro-inflammatory and adaptive immune cytokines in PBMC of vaccinated and unvaccinated pigs naturally exposed to porcine circovirus type 2 (PCV2) infection vary with the occurrence of the disease and the viral burden. Borghetti P, Morganti M, Saleri R, Ferrari L, De Angelis E, Cavalli V, Cacchioli A, Corradi A, Martelli P, Vet Microbiol 2013 163 42 53 10.1016/j.vetmic.2012. 12.007 23290117
11. Porcine circoviruses: a review. Allan GM, Ellis JA, J Vet Diagn Invest 2000 12 3 14 10.1177/104063870001200102 10690769
12. Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS). Nielsen J, Vincent IE, Bøtner A, Ladekaer-Mikkelsen AS, Allan G, Summerfield A, McCullough KC, Vet Immunol Immunopathol 2003 92 97 111 10.1016/S0165-2427(03)00031-X 12730011 (Pubitemid 40221076)
13. Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs. Steiner E, Balmelli C, Gerber H, Summerfield A, McCullough K, BMC Vet Res 2009 5 45 10.1186/1746-6148-5-45 20028550
14. Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2. Shi K, Li H, Guo X, Ge X, Jia H, Zheng S, Yang H, Vet Microbiol 2008 129 367 377 10.1016/j.vetmic.2007.11.020 18164875
15. Effect of porcine circovirus type 2a or 2b on infection kinetics and pathogenicity of two genetically divergent strains of porcine reproductive and respiratory syndrome virus in the conventional pig model. Opriessnig T, Gauger PC, Faaberg KS, Shen H, Beach NM, Meng XJ, Wang C, Halbur PG, Vet Microbiol 2012 158 69 81 22406346
16. Mycoplasma hyopneumoniae bacterins and porcine circovirus type 2 (PCV2) infection: induction of postweaning multisystemic wasting syndrome (PMWS) in the gnotobiotic swine model of PCV2-associated disease. Krakowka S, Ellis J, McNeilly F, Waldner C, Rings DM, Allan G, Can Vet J 2007 48 716 724 17824156 (Pubitemid 47225902)
17. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Fort M, Fernandes LT, Nofrarias M, Díaz I, Sibila M, Pujols J, Mateu E, Segalés J, Vet Immunol Immunopathol 2009 129 101 107 10.1016/j.vetimm.2008.12.024 19167096
18. Changes in peripheral blood leukocyte populations in pigs with natural postweaning multisystemic wasting syndrome (PMWS). Segalés J, Alonso F, Rosell C, Pastor J, Chianini F, Campos E, López-Fuertes L, Quintana J, Rodríguez-Arrioja G, Calsamiglia M, Pujols J, Domínguez J, Domingo M, Vet Immunol Immunopathol 2001 81 37 44 10.1016/S0165-2427(01)00326-9 11498245 (Pubitemid 32717564)
19. Leukogram abnormalities in gnotobiotic pigs infected with porcine circovirus type 2. Gauger PC, Lager KM, Vincent AL, Opriessnig T, Cheung AK, Butler JE, Kehrli ME Jr, Vet Microbiol 2011 154 185 190 10.1016/j.vetmic.2011. 06.016 21784586
20. Changes in CD4(+), CD8(+), CD4(+) CD8(+), and immunoglobulin M-positive peripheral blood mononuclear cells of postweaning multisystemic wasting syndrome-affected pigs and age-matched uninfected wasted and healthy pigs correlate with lesions and porcine circovirus type 2 load in lymphoid tissues. Darwich L, Segalés J, Domingo M, Mateu E, Clin Diagn Lab Immunol 2002 9 236 242 11874858 (Pubitemid 34226012)
21. Distribution and characterization of IL-10-secreting cells in lymphoid tissues of PCV2-infected pigs. Doster AR, Subramaniam S, Yhee JY, Kwon BJ, Yu CH, Kwon SY, Osorio FA, Sur JH, J Vet Sci 2010 11 177 183 10.4142/jvs.2010.11.3. 177 20706023
22. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Fort M, Sibila M, Allepuz A, Mateu E, Roerink F, Segalés J, Vaccine 2008 26 1063 1071 10.1016/j.vaccine.2007.12.019 18237827
23. Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae. Pérez-Martín E, Gómez-Sebastián S, Argilaguet JM, Sibila M, Fort M, Nofrarías M, Kurtz S, Escribano JM, Segalés J, Rodríguez F, Vaccine 2010 28 2340 2349 10.1016/j.vaccine.2009.12.061 20056179
24. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) cap and rep proteins after vaccination with a commercial PCV2 sub-unit vaccine. Fort M, Sibila M, Nofrarías M, Pérez- Martín E, Olvera A, Mateu E, Segalés J, Vet Immunol Immunopathol 2012 150 128 132 10.1016/j.vetimm.2012.09.001 23010221
25. Effects of porcine circovirus type 2 on expression of mRNA associated with endogenous antigen processing and presentation in pulmonary alveolar macrophages and circulating T lymphocytes in piglets. Li J, Yu Q, Nie X, Guo X, Song Q, Li H, Vet J 2012 193 199 205 10.1016/j.tvjl.2011.10.016 22104506
26. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Opriessnig T, Patterson AR, Madson DM, Pal N, Halbur PG, Vaccine 2009 27 1002 1007 10.1016/j.vaccine.2008.11.105 19100807
27. Immune responses and vaccine-induced immunity against porcine circovirus type 2. Kekarainen T, McCullough K, Fort M, Fossum C, Segalés J, Allan GM, Vet Immunol Immunopathol 2010 136 185 193 10.1016/j.vetimm.2010.03.025 20451259
28. Commercial porcine circovirus type 2 vaccines: efficacy and clinical application. Chae C, Vet J 2012 194 151 157 10.1016/j.tvjl.2012.06.031 22841450
29. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Martelli P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Guazzetti S, Caleffi A, Borghetti P, Vet Microbiol 2011 149 339 351 10.1016/j.vetmic.2010.12.008 21216540
30. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs. Martelli P, Ardigò P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Luppi A, Guazzetti S, Caleffi A, Borghetti P, Vet Microbiol 2013 162 558 571 10.1016/j.vetmic.2012.11.016 23206413
31. Proinflammatory cytokine expression in the lung of pigs with porcine circovirus type 2-associated respiratory disease. Chae JS, Choi KS, Res Vet Sci 2011 90 321 323 10.1016/j.rvsc.2010.05.024 20542307
32. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Fort M, Sibila M, Pérez-Martín E, Nofrarías M, Mateu E, Segalés J, Vaccine 2009 27 4031 4037 10.1016/j.vaccine.2009.04.028 19379787
33. Porcine circovirus type 2 (PCV2) cap and rep proteins are involved in the development of cell-mediated immunity upon PCV2 infection. Fort M, Sibila M, Nofrarías M, Pérez-Martín E, Olvera A, Mateu E, Segalés J, Vet Immunol Immunopathol 2010 137 226 234 10.1016/j.vetimm. 2010.05.013 20566220
34. Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge. Seo HW, Oh Y, Han K, Park C, Chae C, BMC Vet Res 2012 8 194 10.1186/1746-6148-8-194 23078878
35. A cluster of farms experiencing severe porcine circovirus associated disease: clinical features and association with the PCV2b genotype. Horlen KP, Schneider P, Anderson J, Nietfeld JC, Henry SC, Tokach LM, Rowland RR, J Swine Health Prod 2007 15 270 278 (Pubitemid 47441363)
36. Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs. Olvera A, Sibila M, Calsamiglia M, Segalés J, Domingo M, J Virol Methods 2004 117 75 80 10.1016/j.jviromet.2003.12.007 15019262 (Pubitemid 38281287)
37. Peripheral T lymphocyte changes in neonatal piglets: relationship with growth hormone (GH), prolactin (PRL) and cortisol changes. Borghetti P, De Angelis E, Saleri R, Cavalli V, Cacchioli A, Corradi A, Mocchegiani E, Martelli P, Vet Immunol Immunopathol 2006 110 17 25 10.1016/j.vetimm.2005.09.001 16213031 (Pubitemid 43201959)
38. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain. Martelli P, Cordioli P, Alborali LG, Gozio S, De Angelis E, Ferrari L, Lombardi G, Borghetti P, Vaccine 2007 25 3400 3408 10.1016/j.vaccine.2006.12.050 17276558 (Pubitemid 46527986)
39. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Martelli P, Gozio S, Ferrari L, Rosina S, De Angelis E, Quintavalla C, Bottarelli E, Borghetti P, Vaccine 2009 27 3788 3799 10.1016/j.vaccine.2009.03. 028 19442420
40. Porcine T lymphocytes and NK cells-an update. Gerner W, Käser T, Saalmüller A, Dev Comp Immunol 2009 33 310 320 10.1016/j.dci.2008.06.003 18601948
41. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection. Ferrari L, Martelli P, Saleri R, De Angelis E, Cavalli V, Bresaola M, Benetti M, Borghetti P, Vet Immunol Immunopathol 2013 151 193 206 10.1016/j.vetimm.2012. 11.006 23228653
42. Swine virus-specific cytotoxic cells producing IFN-gamma under different conditions of virus antigenic stimulation. Ferrari L, De Angelis E, Martelli P, Borghetti P, Vet Res Commun 2010 34 Suppl 1 63 67 20512626
43. Increased per cell IFN-gamma productivity indicates recent in vivo activation of T cells. Schlingmann TR, Shive CL, Targoni OS, Tary-Lehmann M, Lehmann PV, Cell Immunol 2009 258 131 137 10.1016/j.cellimm.2009.04.002 19427634
44. How ELISPOT morphology reflects on the productivity and kinetics of cells' secretory activity. Karulin AY, Lehmann PV, Methods Mol Biol 2012 792 125 143 10.1007/978-1-61779-325-7-11 21956507
45. st century. McCullough KC, Summerfield A, Dev Comp Immunol 2009 33 394 409 10.1016/j.dci.2008.07.015 18771683
46. Enhancement of porcine circovirus 2 replication in porcine cell lines by IFN-gamma before and after treatment and by IFN-alpha after treatment. Meerts P, Misinzo G, Nauwynck HJ, J Interferon Cytokine Res 2005 25 684 693 10.1089/jir.2005.25.684 16318582 (Pubitemid 43010523)
47. Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune cells in early infected pigs. Yu S, Opriessnig T, Kitikoon P, Nilubol D, Halbur PG, Thacker E, Vet Immunol Immunopathol 2007 115 261 272 10.1016/j.vetimm.2006.11.006 17175030 (Pubitemid 46109056)
48. Cellular pathogenesis of porcine circovirus type 2 infection. Dvorak CM, Puvanendiran S, Murtaugh MP, Virus Res 2013 174 60 68 10.1016/j.virusres.2013. 03.001 23499996
49. Change of porcine circovirus 2 target cells in pigs during development from fetal to early postnatal life. Sanchez RE Jr, Meerts P, Nauwynck HJ, Pensaert MB, Vet Microbiol 2003 95 15 25 10.1016/S0378-1135(03)00120-2 12860073 (Pubitemid 36829315)